Anti-HLA-A02:01-peptide (EBV-L
MP2A: CLGGLLTMV) Complex Antibody (MAB243), 抗HLA-A02:01-peptide(EBV-LMP2A: CLGGLLTMV) Complex抗体 (MAB243)- 询价
- abinScience
- China
- HM002013
- 2026年03月03日
- ELISA, FCM, ICC, IF, IHC, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
Anti-HPV16 E7/Protein E7 Antibody (Nb27), 抗HPV16E7/Protein E7抗体 (Nb27)
￥1338
Anti-Human TSLP Antibody (SAA0472), PE, 抗人TSLP抗体 (SAA0472), PE标记
询价Anti-RBD Antibody (AT2F7), 抗RBD抗体 (AT2F7)
￥1338
Anti-CALCA/Calcitonin Polyclonal Antibody, 抗CALCA/Calcitonin多克隆抗体
￥1008Anti-GFP Tag Antibody (N86/8R), 抗GFPTag抗体 (N86/8R)
￥768
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
\
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Mouse
- 目录编号：
HM002013
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Mouse
- 应用范围：
ELISA, FCM, ICC, IF, IHC, WB
- 浓度：
1mg/ml
- 靶点：
\
- 抗体英文名：
Anti-HLA-A02:01-peptide (EBV-LMP2A: CLGGLLTMV) Complex Antibody (MAB243)
- 抗体名：
Anti-HLA-A02:01-peptide (EBV-LMP2A: CLGGLLTMV) Complex Antibody (MAB243)
- 规格：
50ug/100ug/1mg
| Product name | Anti-HLA-A02:01-peptide (EBV-LMP2A: CLGGLLTMV) Complex Antibody (MAB243) |
|---|---|
| Catalog No. | HM002013 |
| Host species | Mouse |
| Species reactivity | Human |
| Immunogen | \ |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, FCM, ICC, IF, IHC, WB |
| Target | \ |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | P04439 & P13285 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Clone ID | MAB243 |
| Note | For research use only |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for ab...
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tetrameric major histocompatibility complex (MHC) class I-peptide complexes (tetramers) are a powerful tool in the study of antigen-specific CD8+ T cell responses (1 ,2 ). Although the interaction of a monomeric MHC-peptide complex
Section.01 RA 发病机制 类风湿性关节炎 (RA) ，其病理核心在于免疫耐受失衡——机体免疫系统未能正确区分“自身”与“异己”，打破了免疫稳态，导致对自身组织产生免疫攻击。 正常情况下，免疫系统能区分自身与异物。但在类风湿患者体内，免疫细胞误将关节滑膜中的瓜氨酸化蛋白识别为“外来敌人”。这种免疫系统“认错人”的现象，导致炎症细胞的快速增殖和活化，主要炎症部位是滑膜。 滑膜组织异常扩张，伴有新生血管形成、内膜过度增生，机体产生类风湿因子 (RF)、抗瓜氨酸化蛋白
Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models2. An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
技术资料暂无技术资料 索取技术资料
